DAILY STOCK DELTA
ARCHIVED EDITION

October 12, 2026

219 namesShare on X

New & updated

219 of 219 names

8Common Ltd

8CO

8Common Ltd's reference price fell 14.29% from A$0.035 on 2026-10-09 to A$0.03 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

8Common Ltd's reference price fell 14.29% from A$0.035 on 2026-10-09 to A$0.03 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Actinogen Medical Limited

ACW

Actinogen Medical Limited's reference price fell 7.27% from A$0.055 on 2026-10-09 to A$0.051 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Actinogen Medical Limited's reference price fell 7.27% from A$0.055 on 2026-10-09 to A$0.051 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

AdNeo Limited

AD1

AdNeo Limited's reference price rose 16.67% from A$0.012 on 2026-10-09 to A$0.014 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

AdNeo Limited's reference price rose 16.67% from A$0.012 on 2026-10-09 to A$0.014 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Adherium Ltd.

ADR

Adherium Ltd.'s reference price fell 9.09% from A$0.077 on 2026-10-09 to A$0.07 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Adherium Ltd.'s reference price fell 9.09% from A$0.077 on 2026-10-09 to A$0.07 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Australian Gold & Copper Ltd.

AGC

Australian Gold & Copper Ltd.'s reference price rose 8.33% from A$0.12 on 2026-10-09 to A$0.13 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Australian Gold & Copper Ltd.'s reference price rose 8.33% from A$0.12 on 2026-10-09 to A$0.13 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Advanced Innergy Holdings Ltd.

AIH

Advanced Innergy Holdings Ltd.'s reference price fell 6.02% from A$0.415 on 2026-10-09 to A$0.39 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Advanced Innergy Holdings Ltd.'s reference price fell 6.02% from A$0.415 on 2026-10-09 to A$0.39 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Arovella Therapeutics Limited

ALA

Arovella Therapeutics Limited's reference price rose 5.77% from A$0.052 on 2026-10-09 to A$0.055 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Arovella Therapeutics Limited's reference price rose 5.77% from A$0.052 on 2026-10-09 to A$0.055 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Altair Minerals limited

ALR

Altair Minerals limited's reference price fell 5.00% from A$0.04 on 2026-10-09 to A$0.038 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Altair Minerals limited's reference price fell 5.00% from A$0.04 on 2026-10-09 to A$0.038 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Alvo Minerals Limited

ALV

Alvo Minerals Limited's reference price rose 7.14% from A$0.07 on 2026-10-09 to A$0.075 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Alvo Minerals Limited's reference price rose 7.14% from A$0.07 on 2026-10-09 to A$0.075 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Almasar Minerals Limited

AMK

Almasar Minerals Limited's reference price rose 6.98% from A$0.215 on 2026-10-09 to A$0.23 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Almasar Minerals Limited's reference price rose 6.98% from A$0.215 on 2026-10-09 to A$0.23 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Agrimin Limited

AMN

Agrimin Limited's reference price fell 8.16% from A$0.049 on 2026-10-09 to A$0.045 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Agrimin Limited's reference price fell 8.16% from A$0.049 on 2026-10-09 to A$0.045 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Ashley Services Group Ltd.

ASH

Ashley Services Group Ltd.'s reference price fell 5.08% from A$0.295 on 2026-10-09 to A$0.28 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Ashley Services Group Ltd.'s reference price fell 5.08% from A$0.295 on 2026-10-09 to A$0.28 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Augustus Minerals Limited

AUG

Augustus Minerals Limited's reference price fell 5.00% from A$0.04 on 2026-10-09 to A$0.038 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Augustus Minerals Limited's reference price fell 5.00% from A$0.04 on 2026-10-09 to A$0.038 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Avada Group Limited

AVD

Avada Group Limited's reference price fell 5.56% from A$0.09 on 2026-10-09 to A$0.085 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Avada Group Limited's reference price fell 5.56% from A$0.09 on 2026-10-09 to A$0.085 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Advance Metals Limited

AVM

Advance Metals Limited's reference price rose 7.14% from A$0.042 on 2026-10-09 to A$0.045 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Advance Metals Limited's reference price rose 7.14% from A$0.042 on 2026-10-09 to A$0.045 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Axiant Resources Limited

AXR

Axiant Resources Limited's reference price fell 6.25% from A$0.16 on 2026-10-09 to A$0.15 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Axiant Resources Limited's reference price fell 6.25% from A$0.16 on 2026-10-09 to A$0.15 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Bridge Saas Limited

BGE

Bridge Saas Limited's reference price fell 12.50% from A$0.008 on 2026-10-09 to A$0.007 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Bridge Saas Limited's reference price fell 12.50% from A$0.008 on 2026-10-09 to A$0.007 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Ballard Mining Limited

BM1

Ballard Mining Limited's reference price fell 9.09% from A$0.715 on 2026-10-09 to A$0.65 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Ballard Mining Limited's reference price fell 9.09% from A$0.715 on 2026-10-09 to A$0.65 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Baumart Holdings Ltd

BMH

Baumart Holdings Ltd's reference price rose 18.18% from A$0.011 on 2026-10-09 to A$0.013 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Baumart Holdings Ltd's reference price rose 18.18% from A$0.011 on 2026-10-09 to A$0.013 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Ballymore Resources Limited

BMR

Ballymore Resources Limited's reference price fell 6.15% from A$0.13 on 2026-10-09 to A$0.122 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Ballymore Resources Limited's reference price fell 6.15% from A$0.13 on 2026-10-09 to A$0.122 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Credit Clear Limited

CCR

Credit Clear Limited's reference price fell 7.41% from A$0.135 on 2026-10-09 to A$0.125 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Credit Clear Limited's reference price fell 7.41% from A$0.135 on 2026-10-09 to A$0.125 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Challenger Gold Limited

CEL

Challenger Gold Limited's reference price fell 5.10% from A$1.57 on 2026-10-09 to A$1.49 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Challenger Gold Limited's reference price fell 5.10% from A$1.57 on 2026-10-09 to A$1.49 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Cogstate Ltd

CGS

Cogstate Ltd's reference price rose 10.14% from A$3.45 on 2026-10-09 to A$3.8 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Cogstate Ltd's reference price rose 10.14% from A$3.45 on 2026-10-09 to A$3.8 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Carma Limited

CMA

Carma Limited's reference price rose 7.25% from A$0.69 on 2026-10-09 to A$0.74 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Carma Limited's reference price rose 7.25% from A$0.69 on 2026-10-09 to A$0.74 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Critical Minerals Group Ltd.

CMG

Critical Minerals Group Ltd.'s reference price rose 6.78% from A$0.059 on 2026-10-09 to A$0.063 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Critical Minerals Group Ltd.'s reference price rose 6.78% from A$0.059 on 2026-10-09 to A$0.063 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Cosol Limited

COS

Cosol Limited's reference price fell 9.52% from A$0.21 on 2026-10-09 to A$0.19 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Cosol Limited's reference price fell 9.52% from A$0.21 on 2026-10-09 to A$0.19 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Cooper Metals Limited

CPM

Cooper Metals Limited's reference price fell 19.35% from A$0.093 on 2026-10-09 to A$0.075 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Cooper Metals Limited's reference price fell 19.35% from A$0.093 on 2026-10-09 to A$0.075 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Cue Energy Resources Limited

CUE

Cue Energy Resources Limited's reference price rose 5.00% from A$0.1 on 2026-10-09 to A$0.105 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Cue Energy Resources Limited's reference price rose 5.00% from A$0.1 on 2026-10-09 to A$0.105 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Caravel Minerals Limited

CVV

Caravel Minerals Limited's reference price fell 11.32% from A$0.265 on 2026-10-09 to A$0.235 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Caravel Minerals Limited's reference price fell 11.32% from A$0.265 on 2026-10-09 to A$0.235 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

CYP.AX (issuer name unverified)

CYP.AX

An unconfirmed report for CYP.AX (issuer name unverified) describes rights issue. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

More details

Investment thesis

An unconfirmed report for CYP.AX (issuer name unverified) describes rights issue. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Corazon Mining Limited

CZN

Corazon Mining Limited's reference price fell 9.09% from A$0.11 on 2026-10-09 to A$0.1 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Corazon Mining Limited's reference price fell 9.09% from A$0.11 on 2026-10-09 to A$0.1 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

CZR Resources Ltd

CZR

CZR Resources Ltd's reference price rose 5.13% from A$0.195 on 2026-10-09 to A$0.205 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

CZR Resources Ltd's reference price rose 5.13% from A$0.195 on 2026-10-09 to A$0.205 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

De.mem Ltd.

DEM

De.mem Ltd.'s reference price rose 13.64% from A$0.11 on 2026-10-09 to A$0.125 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

De.mem Ltd.'s reference price rose 13.64% from A$0.11 on 2026-10-09 to A$0.125 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

E79 Gold Mines Limited

E79

E79 Gold Mines Limited's reference price rose 10.71% from A$0.028 on 2026-10-09 to A$0.031 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

E79 Gold Mines Limited's reference price rose 10.71% from A$0.028 on 2026-10-09 to A$0.031 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Enero Group Limited

EGG

Enero Group Limited's reference price fell 6.38% from A$0.235 on 2026-10-09 to A$0.22 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Enero Group Limited's reference price fell 6.38% from A$0.235 on 2026-10-09 to A$0.22 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Environmental Group Limited

EGL

Environmental Group Limited's reference price rose 10.61% from A$0.066 on 2026-10-09 to A$0.073 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Environmental Group Limited's reference price rose 10.61% from A$0.066 on 2026-10-09 to A$0.073 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Eagle Mountain Mining Ltd.

EM2

Eagle Mountain Mining Ltd.'s reference price rose 20.00% from A$0.005 on 2026-10-09 to A$0.006 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Eagle Mountain Mining Ltd.'s reference price rose 20.00% from A$0.005 on 2026-10-09 to A$0.006 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Emyria Ltd

EMD

Emyria Ltd's reference price fell 7.14% from A$0.042 on 2026-10-09 to A$0.039 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Emyria Ltd's reference price fell 7.14% from A$0.042 on 2026-10-09 to A$0.039 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Encounter Resources Limited

ENR

Encounter Resources Limited's reference price rose 9.80% from A$0.255 on 2026-10-09 to A$0.28 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Encounter Resources Limited's reference price rose 9.80% from A$0.255 on 2026-10-09 to A$0.28 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Enova Mining Limited

ENV

Enova Mining Limited's reference price fell 20.00% from A$0.0025 on 2026-10-09 to A$0.002 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Enova Mining Limited's reference price fell 20.00% from A$0.0025 on 2026-10-09 to A$0.002 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Eclipse Metals Limited

EPM

Eclipse Metals Limited's reference price fell 8.33% from A$0.012 on 2026-10-09 to A$0.011 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Eclipse Metals Limited's reference price fell 8.33% from A$0.012 on 2026-10-09 to A$0.011 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Firebrick Pharma Limited

FRE

Firebrick Pharma Limited's reference price rose 6.90% from A$0.029 on 2026-10-09 to A$0.031 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Firebrick Pharma Limited's reference price rose 6.90% from A$0.029 on 2026-10-09 to A$0.031 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Golden Mile Resources Ltd.

G88

Golden Mile Resources Ltd.'s reference price fell 9.09% from A$0.0055 on 2026-10-09 to A$0.005 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Golden Mile Resources Ltd.'s reference price fell 9.09% from A$0.0055 on 2026-10-09 to A$0.005 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Globe Metals & Mining Limited

GBE

Globe Metals & Mining Limited's reference price fell 5.45% from A$0.055 on 2026-10-09 to A$0.052 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Globe Metals & Mining Limited's reference price fell 5.45% from A$0.055 on 2026-10-09 to A$0.052 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Great Boulder Resources Ltd

GBR

Great Boulder Resources Ltd's reference price rose 6.38% from A$0.094 on 2026-10-09 to A$0.1 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Great Boulder Resources Ltd's reference price rose 6.38% from A$0.094 on 2026-10-09 to A$0.1 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Galan Lithium Limited

GLN

Galan Lithium Limited's reference price fell 9.26% from A$0.27 on 2026-10-09 to A$0.245 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Galan Lithium Limited's reference price fell 9.26% from A$0.27 on 2026-10-09 to A$0.245 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Great Western Exploration Limited

GTE

Great Western Exploration Limited's reference price rose 12.50% from A$0.008 on 2026-10-09 to A$0.009 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Great Western Exploration Limited's reference price rose 12.50% from A$0.008 on 2026-10-09 to A$0.009 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

H3 Energy Limited

H3E

H3 Energy Limited's reference price rose 11.11% from A$0.0045 on 2026-10-09 to A$0.005 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

H3 Energy Limited's reference price rose 11.11% from A$0.0045 on 2026-10-09 to A$0.005 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

HeraMED Ltd

HMD

HeraMED Ltd's reference price fell 5.13% from A$0.039 on 2026-10-09 to A$0.037 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

HeraMED Ltd's reference price fell 5.13% from A$0.039 on 2026-10-09 to A$0.037 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Hamelin Gold Limited

HMG

Hamelin Gold Limited's reference price fell 11.11% from A$0.225 on 2026-10-09 to A$0.2 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Hamelin Gold Limited's reference price fell 11.11% from A$0.225 on 2026-10-09 to A$0.2 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Harris Technology Group Limited

HT8

Harris Technology Group Limited's reference price rose 6.67% from A$0.015 on 2026-10-09 to A$0.016 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Harris Technology Group Limited's reference price rose 6.67% from A$0.015 on 2026-10-09 to A$0.016 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Iceni Gold Ltd.

ICL

Iceni Gold Ltd.'s reference price fell 5.56% from A$0.018 on 2026-10-09 to A$0.017 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Iceni Gold Ltd.'s reference price fell 5.56% from A$0.018 on 2026-10-09 to A$0.017 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Infocus Group Holdings Limited

IFG

Infocus Group Holdings Limited's reference price fell 11.11% from A$0.009 on 2026-10-09 to A$0.008 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Infocus Group Holdings Limited's reference price fell 11.11% from A$0.009 on 2026-10-09 to A$0.008 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

ikeGPS Group Ltd

IKE

ikeGPS Group Ltd's reference price fell 5.56% from A$0.9 on 2026-10-09 to A$0.85 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

ikeGPS Group Ltd's reference price fell 5.56% from A$0.9 on 2026-10-09 to A$0.85 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Jameson Resources Limited

JAL

Jameson Resources Limited's reference price rose 5.88% from A$0.034 on 2026-10-09 to A$0.036 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Jameson Resources Limited's reference price rose 5.88% from A$0.034 on 2026-10-09 to A$0.036 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Jade Gas Holdings Limited

JGH

Jade Gas Holdings Limited's reference price fell 5.80% from A$0.069 on 2026-10-09 to A$0.065 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Jade Gas Holdings Limited's reference price fell 5.80% from A$0.069 on 2026-10-09 to A$0.065 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Kaoko Metals Ltd

KAO

Kaoko is a pre-revenue Namibian copper-silver explorer whose first two holes show positive grades despite a large reported share decline. Further assays, true widths and continuity are catalysts; no resource, metallurgy or mine economics yet support value, and price sources conflict.

More details

Investment thesis

Kaoko is a pre-revenue Namibian copper-silver explorer whose first two holes show positive grades despite a large reported share decline. Further assays, true widths and continuity are catalysts; no resource, metallurgy or mine economics yet support value, and price sources conflict.

Risk / thesis breaker

['unsupported FY1/FY2 and matched peers', 'official adjusted CSPA not verified', 'current gross capital/cash and exact account permission unresolved']

Kip McGrath Education Centres Limited

KME

Tutoring provider with an unconditional A$0.75 cash offer closing October19. At indicative A$0.69, a new ex-dividend buyer might receive1.087x cash, but the deed and entitlement footnote disagree on whether six cents is deducted. Payment interpretation, funding and minority illiquidity are the main breakers.

More details

Investment thesis

Tutoring provider with an unconditional A$0.75 cash offer closing October19. At indicative A$0.69, a new ex-dividend buyer might receive1.087x cash, but the deed and entitlement footnote disagree on whether six cents is deducted. Payment interpretation, funding and minority illiquidity are the main breakers.

Risk / thesis breaker

Dividend/rights treatment; bidder funding/payment delay; acceptance mechanics; minority illiquidity; incomplete audits

Kingston Resources Ltd.

KSN

Kingston Resources Ltd.'s reference price fell 5.71% from A$0.035 on 2026-10-09 to A$0.033 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Kingston Resources Ltd.'s reference price fell 5.71% from A$0.035 on 2026-10-09 to A$0.033 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Little Green Pharma Ltd.

LGP

Little Green Pharma Ltd.'s reference price rose 7.81% from A$0.064 on 2026-10-09 to A$0.069 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Little Green Pharma Ltd.'s reference price rose 7.81% from A$0.064 on 2026-10-09 to A$0.069 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Lifestyle Communities Ltd

LIC

Lifestyle Communities Ltd's reference price fell 9.72% from A$4.22 on 2026-10-09 to A$3.81 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Lifestyle Communities Ltd's reference price fell 9.72% from A$4.22 on 2026-10-09 to A$3.81 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

MB Gold Limited

MBG

MB Gold Limited's reference price fell 7.32% from A$0.205 on 2026-10-09 to A$0.19 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

MB Gold Limited's reference price fell 7.32% from A$0.205 on 2026-10-09 to A$0.19 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Metro Mining Limited

MMI

Metro Mining Limited's reference price fell 25.42% from A$1.18 on 2026-10-09 to A$0.88 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Metro Mining Limited's reference price fell 25.42% from A$1.18 on 2026-10-09 to A$0.88 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Macallum New Energy Limited

MNE

Macallum New Energy Limited's reference price fell 5.71% from A$0.175 on 2026-10-09 to A$0.165 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Macallum New Energy Limited's reference price fell 5.71% from A$0.175 on 2026-10-09 to A$0.165 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Monvia Limited

MNV

Monvia Limited's reference price fell 6.80% from A$1.03 on 2026-10-09 to A$0.96 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Monvia Limited's reference price fell 6.80% from A$1.03 on 2026-10-09 to A$0.96 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

MOVe Logistics Group Limited

MOV

MOVe Logistics Group Limited's reference price fell 19.44% from A$0.18 on 2026-10-09 to A$0.145 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

MOVe Logistics Group Limited's reference price fell 19.44% from A$0.18 on 2026-10-09 to A$0.145 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

NH3 Clean Energy Limited

NH3

NH3 Clean Energy Limited's reference price rose 8.43% from A$0.083 on 2026-10-09 to A$0.09 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

NH3 Clean Energy Limited's reference price rose 8.43% from A$0.083 on 2026-10-09 to A$0.09 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Nimy Resources Limited

NIM

Nimy Resources Limited's reference price rose 5.41% from A$0.037 on 2026-10-09 to A$0.039 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Nimy Resources Limited's reference price rose 5.41% from A$0.037 on 2026-10-09 to A$0.039 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

New Murchison Gold Limited

NMG

New Murchison Gold Limited's reference price fell 6.06% from A$0.066 on 2026-10-09 to A$0.062 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

New Murchison Gold Limited's reference price fell 6.06% from A$0.066 on 2026-10-09 to A$0.062 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Nordic Resources Limited.

NNL

Nordic Resources Limited.'s reference price rose 5.71% from A$0.175 on 2026-10-09 to A$0.185 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Nordic Resources Limited.'s reference price rose 5.71% from A$0.175 on 2026-10-09 to A$0.185 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

NewPeak Metals Limited

NPM

Exploration company with less than one quarter of cash runway at the reported burn. A full historical mark liquidation of its LKO holding extends runway only to1.267quarters; saleability, drilling spend and dilutive financing remain the central risks.

More details

Investment thesis

Exploration company with less than one quarter of cash runway at the reported burn. A full historical mark liquidation of its LKO holding extends runway only to1.267quarters; saleability, drilling spend and dilutive financing remain the central risks.

Risk / thesis breaker

Further dilution, uncertain saleability/price/encumbrance of LKO stake, exploration metallurgy/resource/economic uncertainty, broker local-security access unverified.

Nuchev Pty Ltd

NUC

Nuchev Pty Ltd's reference price fell 5.88% from A$0.085 on 2026-10-09 to A$0.08 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Nuchev Pty Ltd's reference price fell 5.88% from A$0.085 on 2026-10-09 to A$0.08 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Octava Minerals Ltd.

OCT

Octava Minerals Ltd.'s reference price fell 9.09% from A$0.022 on 2026-10-09 to A$0.02 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Octava Minerals Ltd.'s reference price fell 9.09% from A$0.022 on 2026-10-09 to A$0.02 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Orcoda Limited

ODA

Orcoda Limited's reference price rose 7.27% from A$0.055 on 2026-10-09 to A$0.059 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Orcoda Limited's reference price rose 7.27% from A$0.055 on 2026-10-09 to A$0.059 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

OpenLearning Ltd.

OLL

OpenLearning Ltd.'s reference price fell 7.69% from A$0.013 on 2026-10-09 to A$0.012 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

OpenLearning Ltd.'s reference price fell 7.69% from A$0.013 on 2026-10-09 to A$0.012 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

PHX (issuer name unverified)

PHX

PHX has a Q1 FY2027 investor-update announcement, but no supported recurring-profit or cash-flow case is established. The operating catalyst, capital needs and valuation are unknown, so weak cash conversion or dilution could invalidate the setup.

More details

Investment thesis

PHX has a Q1 FY2027 investor-update announcement, but no supported recurring-profit or cash-flow case is established. The operating catalyst, capital needs and valuation are unknown, so weak cash conversion or dilution could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Peak Processing Limited

PKP

Peak Processing Limited's reference price fell 5.88% from A$0.017 on 2026-10-09 to A$0.016 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Peak Processing Limited's reference price fell 5.88% from A$0.017 on 2026-10-09 to A$0.016 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Paterson Resources Limited

PSL

Paterson Resources Limited's reference price rose 5.13% from A$0.039 on 2026-10-09 to A$0.041 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Paterson Resources Limited's reference price rose 5.13% from A$0.039 on 2026-10-09 to A$0.041 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

PVE (issuer name unverified)

PVE

PVE has a dividend/distribution announcement, creating a potential cash-return event. The amount, entitlement and funding are not established here; an ex-dividend price adjustment or insufficient residual cash could eliminate any apparent gain.

More details

Investment thesis

PVE has a dividend/distribution announcement, creating a potential cash-return event. The amount, entitlement and funding are not established here; an ex-dividend price adjustment or insufficient residual cash could eliminate any apparent gain.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Rectifier Technologies Ltd

RFT

Rectifier Technologies Ltd's reference price rose 9.09% from A$0.0055 on 2026-10-09 to A$0.006 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Rectifier Technologies Ltd's reference price rose 9.09% from A$0.0055 on 2026-10-09 to A$0.006 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Rand Mining Limited

RND

Rand Mining Limited's reference price rose 9.76% from A$2.05 on 2026-10-09 to A$2.25 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Rand Mining Limited's reference price rose 9.76% from A$2.05 on 2026-10-09 to A$2.25 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Richmond Vanadium Technology Pty Ltd.

RVT

Richmond Vanadium Technology Pty Ltd.'s reference price rose 5.00% from A$0.1 on 2026-10-09 to A$0.105 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Richmond Vanadium Technology Pty Ltd.'s reference price rose 5.00% from A$0.1 on 2026-10-09 to A$0.105 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Rubicon Water Limited

RWL

Rubicon Water Limited's reference price fell 6.15% from A$0.325 on 2026-10-09 to A$0.305 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Rubicon Water Limited's reference price fell 6.15% from A$0.325 on 2026-10-09 to A$0.305 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Sabre Resources Ltd

SBR

Sabre Resources Ltd's reference price fell 14.29% from A$0.007 on 2026-10-09 to A$0.006 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Sabre Resources Ltd's reference price fell 14.29% from A$0.007 on 2026-10-09 to A$0.006 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Star Minerals Ltd.

SMS

Star Minerals Ltd.'s reference price fell 5.13% from A$0.039 on 2026-10-09 to A$0.037 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Star Minerals Ltd.'s reference price fell 5.13% from A$0.039 on 2026-10-09 to A$0.037 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Sentinel Metals Limited

SNM

Sentinel Metals Limited's reference price fell 20.20% from A$0.495 on 2026-10-09 to A$0.395 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Sentinel Metals Limited's reference price fell 20.20% from A$0.495 on 2026-10-09 to A$0.395 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Summerset Group Holdings Limited

SNZ

Summerset Group Holdings Limited's reference price rose 5.77% from A$5.2 on 2026-10-09 to A$5.5 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Summerset Group Holdings Limited's reference price rose 5.77% from A$5.2 on 2026-10-09 to A$5.5 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

SPC Global Holdings Ltd

SPG

SPC Global Holdings Ltd's reference price fell 5.26% from A$0.076 on 2026-10-09 to A$0.072 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

SPC Global Holdings Ltd's reference price fell 5.26% from A$0.076 on 2026-10-09 to A$0.072 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

StepChange Holdings Ltd.

STH

StepChange Holdings Ltd.'s reference price fell 11.11% from A$0.135 on 2026-10-09 to A$0.12 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

StepChange Holdings Ltd.'s reference price fell 11.11% from A$0.135 on 2026-10-09 to A$0.12 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Thorney Technologies Limited

TEK

Thorney Technologies Limited's reference price rose 5.00% from A$0.1 on 2026-10-09 to A$0.105 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Thorney Technologies Limited's reference price rose 5.00% from A$0.1 on 2026-10-09 to A$0.105 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

TerraCom Limited

TER

TerraCom Limited's reference price rose 6.35% from A$0.063 on 2026-10-09 to A$0.067 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

TerraCom Limited's reference price rose 6.35% from A$0.063 on 2026-10-09 to A$0.067 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Titan Minerals Ltd

TTM

Titan Minerals Ltd's reference price fell 6.36% from A$0.55 on 2026-10-09 to A$0.515 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Titan Minerals Ltd's reference price fell 6.36% from A$0.55 on 2026-10-09 to A$0.515 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Tivan Limited

TVN

Tivan Limited's reference price fell 7.89% from A$0.19 on 2026-10-09 to A$0.175 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Tivan Limited's reference price fell 7.89% from A$0.19 on 2026-10-09 to A$0.175 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

TZ Limited

TZL

TZ Limited's reference price fell 15.38% from A$0.026 on 2026-10-09 to A$0.022 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

TZ Limited's reference price fell 15.38% from A$0.026 on 2026-10-09 to A$0.022 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Vulcan Steel Ltd.

VSL

Vulcan Steel Ltd.'s reference price fell 5.85% from A$5.47 on 2026-10-09 to A$5.15 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Vulcan Steel Ltd.'s reference price fell 5.85% from A$5.47 on 2026-10-09 to A$5.15 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

WT Financial Group Ltd.

WTL

WT Financial Group Ltd.'s reference price fell 6.25% from A$0.16 on 2026-10-09 to A$0.15 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

WT Financial Group Ltd.'s reference price fell 6.25% from A$0.16 on 2026-10-09 to A$0.15 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Zimplats Holdings Limited

ZIM

Zimplats Holdings Limited's reference price fell 5.93% from A$15 on 2026-10-09 to A$14.11 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Zimplats Holdings Limited's reference price fell 5.93% from A$15 on 2026-10-09 to A$14.11 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Zip Co Ltd.

ZIP

Zip Co Ltd.'s reference price rose 5.56% from A$2.16 on 2026-10-09 to A$2.28 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Zip Co Ltd.'s reference price rose 5.56% from A$2.16 on 2026-10-09 to A$2.28 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Zinc of Ireland Limited

ZMI

Zinc of Ireland Limited's reference price rose 5.00% from A$0.02 on 2026-10-09 to A$0.021 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

More details

Investment thesis

Zinc of Ireland Limited's reference price rose 5.00% from A$0.02 on 2026-10-09 to A$0.021 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

ACO-X.TO (issuer name unverified)

ACO-X.TO

An unconfirmed report for ACO-X.TO (issuer name unverified) describes merger with $EMA.TO at 0.865x shares+SpinCo. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

More details

Investment thesis

An unconfirmed report for ACO-X.TO (issuer name unverified) describes merger with $EMA.TO at 0.865x shares+SpinCo. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Alimentation Couche-Tard

ATD

Alimentation Couche-Tard has an Irving asset-acquisition headline that could change its operating footprint. Purchase terms, acquired cash flow and funding are unknown; overpayment, financing or integration costs could absorb any benefit.

More details

Investment thesis

Alimentation Couche-Tard has an Irving asset-acquisition headline that could change its operating footprint. Purchase terms, acquired cash flow and funding are unknown; overpayment, financing or integration costs could absorb any benefit.

Risk / thesis breaker

Unknown until primary body and financial security bridge read.

Aritzia Inc.

ATZ

Aritzia has strong store and digital demand, with 34.5% comparable-sales growth supporting its retail expansion. The margin jump includes C$97.4m tariff refunds, however, while inventory and infrastructure spending rise. Harder comparisons, recurring compensation and distribution costs could leave shareholder cash well below headline earnings.

More details

Investment thesis

Aritzia has strong store and digital demand, with 34.5% comparable-sales growth supporting its retail expansion. The margin jump includes C$97.4m tariff refunds, however, while inventory and infrastructure spending rise. Harder comparisons, recurring compensation and distribution costs could leave shareholder cash well below headline earnings.

Risk / thesis breaker

Fashion/traffic reversal, inventory up36%, tariffs, harder comparisons and DC depreciation; adjusted earnings exclusions.

CU.TO (issuer name unverified)

CU.TO

An unconfirmed report for CU.TO (issuer name unverified) describes merger with $EMA.TO at 0.755x. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

More details

Investment thesis

An unconfirmed report for CU.TO (issuer name unverified) describes merger with $EMA.TO at 0.755x. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Dye & Durham

DND

Legal/business software provider cutting costs against a heavy interest burden. Remaining C$6-8m savings leave the strict owner-cash sensitivity near breakeven after recurring SBC; covenant compliance, revenue retention and reinvestment can overwhelm the cuts.

More details

Investment thesis

Legal/business software provider cutting costs against a heavy interest burden. Remaining C$6-8m savings leave the strict owner-cash sensitivity near breakeven after recurring SBC; covenant compliance, revenue retention and reinvestment can overwhelm the cuts.

Risk / thesis breaker

Debt interest/covenants, reinvestment and transition cash, customer retention, savings realization and dilution.

Grupo Empresarial San José

GSJ

San José has a €47.96m public-housing design/build contract over 48 months. It adds work but is small relative to group revenue, and customer advances and guarantees constrain headline cash. Cost overruns, payment delays or minority allocations could prevent the order from creating meaningful common-share value.

More details

Investment thesis

San José has a €47.96m public-housing design/build contract over 48 months. It adds work but is small relative to group revenue, and customer advances and guarantees constrain headline cash. Cost overruns, payment delays or minority allocations could prevent the order from creating meaningful common-share value.

Risk / thesis breaker

XML202 empty; procurement funding/payment and normalized forward economics unverified.

Dynagreen Environmental Protection Group

01330

Dynagreen says its capex peak has passed and collections are stable, potentially improving cash available for dividends. The proposed 2027-29 payout floor is conditional, not a forward earnings forecast. Receivable collection, maintenance capex and convertible dilution could prevent the cash-return thesis from reaching H-share holders.

More details

Investment thesis

Dynagreen says its capex peak has passed and collections are stable, potentially improving cash available for dividends. The proposed 2027-29 payout floor is conditional, not a forward earnings forecast. Receivable collection, maintenance capex and convertible dilution could prevent the cash-return thesis from reaching H-share holders.

Risk / thesis breaker

Published network text interaction, not audio; convertible funding/conversion question partly unanswered; current H-share price and dilution unverified.

CLP Holdings Limited

0002

No supported investment thesis is established for CLP Holdings from the unconfirmed Q3 event label. Earnings, cash generation and a concrete catalyst are unknown; adverse results, financing needs or an incorrect event identity could invalidate the setup.

More details

Investment thesis

No supported investment thesis is established for CLP Holdings from the unconfirmed Q3 event label. Earnings, cash generation and a concrete catalyst are unknown; adverse results, financing needs or an incorrect event identity could invalidate the setup.

Risk / thesis breaker

Unknown call identity/timezone and missing free transcript.

Computime Group Limited

00320

Computime could improve profits through Mexico ramp absorption and a better controls and Salus mix. The analyst recovery case nearly triples profit, but sustainable cash is unproven, parent liquidity is minimal and the dated HK$0.44 quotation had no trades. Poor margin conversion or continuing development funding would break the recovery case.

More details

Investment thesis

Computime could improve profits through Mexico ramp absorption and a better controls and Salus mix. The analyst recovery case nearly triples profit, but sustainable cash is unproven, parent liquidity is minimal and the dated HK$0.44 quotation had no trades. Poor margin conversion or continuing development funding would break the recovery case.

Risk / thesis breaker

['Mexico ramp', 'Factoring and capitalized development', 'Parent cash', 'Zero trade liquidity']

Hengdeli Holdings Limited

3389.HK

Hengdeli proposes a HK$0.266-per-share capital return against a HK$0.32 dated reference price. Approval and solvency could release substantial cash, but the payout is not earnings or a guaranteed profit: residual business value, available parent cash and actual payment remain unresolved.

More details

Investment thesis

Hengdeli proposes a HK$0.266-per-share capital return against a HK$0.32 dated reference price. Approval and solvency could release substantial cash, but the payout is not earnings or a guaranteed profit: residual business value, available parent cash and actual payment remain unresolved.

Risk / thesis breaker

Nonwaivable approval/solvency conditions, ongoing residual losses, common-owner cash availability, NCI, taxes, postJune burn, ex-div price adjustment.

신라섬유 (English name unverified)

001000신라섬유

신라섬유 is a small textile issue with a price-limit discovery, not an established earnings inflection. Property value, recurring profit and financing are unknown; weak cash or senior claims could erase the price-based opportunity.

More details

Investment thesis

신라섬유 is a small textile issue with a price-limit discovery, not an established earnings inflection. Property value, recurring profit and financing are unknown; weak cash or senior claims could erase the price-based opportunity.

Risk / thesis breaker

small textile issue; property/earnings/financing unreviewed.

알파칩스 (English name unverified)

117670알파칩스

알파칩스 has a one-for-one bonus issue, which does not itself create economic value. Recurring earnings and cash remain unknown; weaker profits or dilution can overwhelm any price response to the share-count change.

More details

Investment thesis

알파칩스 has a one-for-one bonus issue, which does not itself create economic value. Recurring earnings and cash remain unknown; weaker profits or dilution can overwhelm any price response to the share-count change.

Risk / thesis breaker

1-for-1 issue does not create economic value; issuer earnings/FCF still unreviewed.

뉴인텍 (English name unverified)

012340뉴인텍

뉴인텍 has electronic-component exposure, but orders, cash generation and capital survival are unproven. A price response without funded demand or sustainable margins could reverse, and financing claims could dominate common value.

More details

Investment thesis

뉴인텍 has electronic-component exposure, but orders, cash generation and capital survival are unproven. A price response without funded demand or sustainable margins could reverse, and financing claims could dominate common value.

Risk / thesis breaker

electronic components; capital survival/orders/cash unreviewed.

BGF에코머티리얼즈 (English name unverified)

126600

BGF에코머티리얼즈 has a funded tender deposit and a new buyback trust, providing concrete shareholder-return mechanisms. Full acceptance at the captured price is only a gross sensitivity; proration, taxes and access can reduce proceeds. A related-party asset transfer is not an external group-wide windfall.

More details

Investment thesis

BGF에코머티리얼즈 has a funded tender deposit and a new buyback trust, providing concrete shareholder-return mechanisms. Full acceptance at the captured price is only a gross sensitivity; proration, taxes and access can reduce proceeds. A related-party asset transfer is not an external group-wide windfall.

Risk / thesis breaker

Proration; deemed-dividend/withholding disclosure; NH account and citizenship/residency/IBKR eligibility; related-party fairness; lost KNW earnings and fresh-share repurchase execution.

나래나노텍 (English name unverified)

137080

나래나노텍 plans repurchases for cancellation, which could reduce shares if executed and retained. The mandate itself is not earnings or cash paid to every holder; execution, compensation and recurring profit determine whether the per-share benefit survives.

More details

Investment thesis

나래나노텍 plans repurchases for cancellation, which could reduce shares if executed and retained. The mandate itself is not earnings or cash paid to every holder; execution, compensation and recurring profit determine whether the per-share benefit survives.

Risk / thesis breaker

Order-cycle deterioration; execution/liquidity and unverified future owner earnings; no announcement-to-profit substitution.

메디앙스 (English name unverified)

014100

메디앙스 has share-purchase mechanics, but employee delivery can restore economic shares and create compensation costs. The apparent capital-return percentage is not permanent shareholder value; dilution, expenses and weak recurring earnings could invalidate it.

More details

Investment thesis

메디앙스 has share-purchase mechanics, but employee delivery can restore economic shares and create compensation costs. The apparent capital-return percentage is not permanent shareholder value; dilution, expenses and weak recurring earnings could invalidate it.

Risk / thesis breaker

Employee compensation/reissue; no cancellation commitment in the reviewed filing; weak liquidity and unsupported normalized economics.

대교 (English name unverified)

019685대교

대교 has a treasury-share disposal-result filing. The transaction could alter capital and ownership, but proceeds, compensation costs and recurring earnings are unknown; dilution or poor use of cash could defeat any shareholder benefit.

More details

Investment thesis

대교 has a treasury-share disposal-result filing. The transaction could alter capital and ownership, but proceeds, compensation costs and recurring earnings are unknown; dilution or poor use of cash could defeat any shareholder benefit.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

뱅크웨어글로벌 (English name unverified)

199480

뱅크웨어글로벌 has a visible delivery backlog with 30% advances and further payments at acceptance. Advances can finance delivery but are not profit, and revenue spans 2026-27. Cost overruns, delayed acceptance or low margins could prevent the backlog from becoming common-share cash.

More details

Investment thesis

뱅크웨어글로벌 has a visible delivery backlog with 30% advances and further payments at acceptance. Advances can finance delivery but are not profit, and revenue spans 2026-27. Cost overruns, delayed acceptance or low margins could prevent the backlog from becoming common-share cash.

Risk / thesis breaker

Bank/customer concentration; fixed-scope execution over14months; design/final acceptance and delay provisions; cash timing.

휴마시스 (English name unverified)

205470휴마시스

휴마시스 has a diagnostic-demand theme, but actual orders and recurring margins are unknown. Paid demand could matter, while funding needs or a short-lived thematic spike could invalidate the setup.

More details

Investment thesis

휴마시스 has a diagnostic-demand theme, but actual orders and recurring margins are unknown. Paid demand could matter, while funding needs or a short-lived thematic spike could invalidate the setup.

Risk / thesis breaker

diagnostic theme; actual orders/recurring margins/funding unreviewed.

본느 (English name unverified)

226340본느

본느 has cosmetics exposure and touched a price limit before a negative close. No operating catalyst or recurring cash case is established; weak demand, funding or reversal could erase the apparent opportunity.

More details

Investment thesis

본느 has cosmetics exposure and touched a price limit before a negative close. No operating catalyst or recurring cash case is established; weak demand, funding or reversal could erase the apparent opportunity.

Risk / thesis breaker

cosmetics; touch then negative close, actual catalyst/earnings/cash unreviewed.

유진테크놀로지 (English name unverified)

240600유진테크놀로지

유진테크놀로지 has battery-production equipment exposure, but order margins, working capital and debt are unknown. Conversion of orders into paid profitable deliveries could matter; cost overruns or financing could absorb the benefit.

More details

Investment thesis

유진테크놀로지 has battery-production equipment exposure, but order margins, working capital and debt are unknown. Conversion of orders into paid profitable deliveries could matter; cost overruns or financing could absorb the benefit.

Risk / thesis breaker

battery-production equipment; order margin/WC/debt unreviewed.

국제약품 (English name unverified)

002720국제약품

국제약품 has a pharmaceutical-demand theme without a verified company-specific profit catalyst. Sustainable earnings and cash are unknown; unfulfilled demand, funding or price reversal could invalidate the setup.

More details

Investment thesis

국제약품 has a pharmaceutical-demand theme without a verified company-specific profit catalyst. Sustainable earnings and cash are unknown; unfulfilled demand, funding or price reversal could invalidate the setup.

Risk / thesis breaker

pharmaceutical demand theme; exact catalyst/earnings/cash unreviewed.

SUN&L

002820

SUN&L has asset-sale and cancellation claims, potentially affecting capital returns. Actual proceeds, debt and core earnings are unknown; senior claims, failed execution or poor reinvestment could absorb any benefit.

More details

Investment thesis

SUN&L has asset-sale and cancellation claims, potentially affecting capital returns. Actual proceeds, debt and core earnings are unknown; senior claims, failed execution or poor reinvestment could absorb any benefit.

Risk / thesis breaker

asset-sale/cancellation claims; actual cash proceeds/debt/core business unreviewed.

플리토 (English name unverified)

300080

플리토 has near-term solution and SI delivery payments, but the license/labor mix is undisclosed and not proven recurring SaaS revenue. A separate earlier purchase order was cut materially. Delivery costs, customer concentration or further amendments could absorb the apparent growth.

More details

Investment thesis

플리토 has near-term solution and SI delivery payments, but the license/labor mix is undisclosed and not proven recurring SaaS revenue. A separate earlier purchase order was cut materially. Delivery costs, customer concentration or further amendments could absorb the apparent growth.

Risk / thesis breaker

Customer secrecy; cancellation/amendment and labor delivery; unrelated old PO collection still pendingFeb9,2027.

HLB글로벌 (English name unverified)

003580HLB글로벌

HLB글로벌 has group-restructuring exposure, but merger, convertible and attributable recurring earnings terms are unresolved. The transaction could alter common claims, while dilution or weak underlying cash could dominate the outcome.

More details

Investment thesis

HLB글로벌 has group-restructuring exposure, but merger, convertible and attributable recurring earnings terms are unresolved. The transaction could alter common claims, while dilution or weak underlying cash could dominate the outcome.

Risk / thesis breaker

group restructuring; merger/CB and recurring attributable earnings unreviewed.

SAMKEE ENERGY SOLUTIONS Co.,LTD

419050삼기에너지솔루션즈

Samkee Energy Solutions grew revenue 73% while operating profit fell 12%, and owner cash was negative KRW6.062bn. Sales growth is not recurring cheapness; margins, other income, minorities and funding could prevent it reaching shareholders.

More details

Investment thesis

Samkee Energy Solutions grew revenue 73% while operating profit fell 12%, and owner cash was negative KRW6.062bn. Sales growth is not recurring cheapness; margins, other income, minorities and funding could prevent it reaching shareholders.

Risk / thesis breaker

revenue +73%, OP -12%; owner cash -6.062bn; historical diluted repetition12.97x, not forward. IR/other-income/NCI gates.

SAMG ENTERTAINMENT CO.,LTD

419530SAMG엔터

SAMG Entertainment has an IP and content-slate opportunity, but H1 operating profit fell 49% and owner cash was negative KRW11.051bn. Preference claims, cash conversion and taxes could prevent the franchise from producing common-share value.

More details

Investment thesis

SAMG Entertainment has an IP and content-slate opportunity, but H1 operating profit fell 49% and owner cash was negative KRW11.051bn. Preference claims, cash conversion and taxes could prevent the franchise from producing common-share value.

Risk / thesis breaker

H1 OP -49%; owner cash -11.051bn; historical repetition23.76x, not forward. IP/slate/preference/tax gates.

HLB파나진 (English name unverified)

046210HLB파나진

HLB파나진 has PNA diagnostic exposure, but paid orders and recurring margins are unproven. Commercial uptake could matter; funding, dilution or weak realized demand could invalidate the theme.

More details

Investment thesis

HLB파나진 has PNA diagnostic exposure, but paid orders and recurring margins are unproven. Commercial uptake could matter; funding, dilution or weak realized demand could invalidate the theme.

Risk / thesis breaker

PNA diagnostics; paid orders/recurring margins/dilution unreviewed.

천일고속 (English name unverified)

000650천일고속

천일고속 has terminal-asset exposure, but historical losses and unresolved ownership and project distributions prevent a cash-value conclusion. Creditor claims, funding or a lack of realized distributions could break the asset thesis.

More details

Investment thesis

천일고속 has terminal-asset exposure, but historical losses and unresolved ownership and project distributions prevent a cash-value conclusion. Creditor claims, funding or a lack of realized distributions could break the asset thesis.

Risk / thesis breaker

H1 EPS-2172; terminal book32.027bn versus315.143bn cap; ownership/project distributions unresolved.

DONGYANG EXPRESS CORP.

084670동양고속

Dongyang Express has a small terminal stake and historical losses, not proven shareholder recovery. Property title, debt and distributions remain unresolved; senior claims or poor realization could absorb the asset value.

More details

Investment thesis

Dongyang Express has a small terminal stake and historical losses, not proven shareholder recovery. Property title, debt and distributions remain unresolved; senior claims or poor realization could absorb the asset value.

Risk / thesis breaker

terminal stake0.16%; H1 EPS-914; property/title/debt waterfall unresolved.

NEXT.OL (issuer name unverified)

NEXT.OL

An unconfirmed report for NEXT.OL (issuer name unverified) describes planned bankruptcy filing. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

More details

Investment thesis

An unconfirmed report for NEXT.OL (issuer name unverified) describes planned bankruptcy filing. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Glintt Global

GLINT

Glintt has a €667,575, 24-month contract, not a €66.76m award. Consortium allocation is unknown and the order is small relative to revenue. Wage inflation, capitalized costs and customer-funded cash could overwhelm its profit contribution, so the award alone does not support a rerating.

More details

Investment thesis

Glintt has a €667,575, 24-month contract, not a €66.76m award. Consortium allocation is unknown and the order is small relative to revenue. Wage inflation, capitalized costs and customer-funded cash could overwhelm its profit contribution, so the award alone does not support a rerating.

Risk / thesis breaker

XML202 empty; economic own allocation and current price unknown.

ORX.ST (issuer name unverified)

ORX.ST

An unconfirmed report for ORX.ST (issuer name unverified) describes rights issue. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

More details

Investment thesis

An unconfirmed report for ORX.ST (issuer name unverified) describes rights issue. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

LDROBOT

01236

LDROBOT has an announced acquisition of SABO-Maschinenfabrik. Consideration, acquired profit and funding are unknown; overpayment, integration costs or dilution could absorb any operating benefit.

More details

Investment thesis

LDROBOT has an announced acquisition of SABO-Maschinenfabrik. Consideration, acquired profit and funding are unknown; overpayment, integration costs or dilution could absorb any operating benefit.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

ESWIN COMPUTING

01256

ESWIN Computing has final offer-price and allotment news, but no supported earnings or cash-flow valuation case is established. Offering terms, dilution and cash needs determine whether the listing creates common-share value.

More details

Investment thesis

ESWIN Computing has final offer-price and allotment news, but no supported earnings or cash-flow valuation case is established. Offering terms, dilution and cash needs determine whether the listing creates common-share value.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

VPOWER GROUP

01608

VPOWER has an update on proposed restructuring, which could alter debt and common claims. The completed terms and recurring business economics are unknown; creditor priority or dilution could consume any recovery.

More details

Investment thesis

VPOWER has an update on proposed restructuring, which could alter debt and common claims. The completed terms and recurring business economics are unknown; creditor priority or dilution could consume any recovery.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Dongyue Group Limited

00189

Dongyue has a sharp nine-month profit inflection at its organosilicone subsidiary. The catalyst is real subsidiary recovery, but parent ownership, minority claims, cycle prices and recurring adjustments are not bridged to common earnings; no forward P/E is established.

More details

Investment thesis

Dongyue has a sharp nine-month profit inflection at its organosilicone subsidiary. The catalyst is real subsidiary recovery, but parent ownership, minority claims, cycle prices and recurring adjustments are not bridged to common earnings; no forward P/E is established.

Risk / thesis breaker

['Cyclical silicone prices', 'Unaudited management estimate', 'Minority ownership', 'Nonrecurring adjustment definition', 'Parent financial bridge incomplete']

Ritamix Global Limited

01936

Ritamix declares a HK$0.29 capital distribution,10% of its HK$2.90 dated close, by reallocating abandoned plant-expansion IPO funds. Dividend entitlement is the catalyst, but ex-dividend adjustment, parent cash and control-offer deductions prevent treating yield as total return.

More details

Investment thesis

Ritamix declares a HK$0.29 capital distribution,10% of its HK$2.90 dated close, by reallocating abandoned plant-expansion IPO funds. Dividend entitlement is the catalyst, but ex-dividend adjustment, parent cash and control-offer deductions prevent treating yield as total return.

Risk / thesis breaker

['Ex-dividend price adjustment', 'Control-sale offer terms and funding', 'Abandoned expansion', 'Distributable parent cash unverified']

PLUS GP HOLDING

02486

PLUS GP has connected acquisitions of subsidiary equity that could change its assets and income. Purchase price, ownership and financing are unknown; unfavorable related-party terms could transfer value away from common holders.

More details

Investment thesis

PLUS GP has connected acquisitions of subsidiary equity that could change its assets and income. Purchase price, ownership and financing are unknown; unfavorable related-party terms could transfer value away from common holders.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Xinhua News Media Holdings Limited

00309

Xinhua corrects the record of a153m-share debt settlement that completed in May, not fresh October cash. Separate placing and court/validation deadlines remain unresolved; duplicate-counted dilution, winding-up risk and stale price evidence prevent a cash-value conclusion.

More details

Investment thesis

Xinhua corrects the record of a153m-share debt settlement that completed in May, not fresh October cash. Separate placing and court/validation deadlines remain unresolved; duplicate-counted dilution, winding-up risk and stale price evidence prevent a cash-value conclusion.

Risk / thesis breaker

['Winding-up/validation conditions inherited', 'Duplicate-counted shares', 'No new cash from debt settlement', 'Stale quote']

CNBM

03323

CNBM has a subscription and deemed-disposal transaction involving Sinoma Science & Technology. Parent ownership, consideration and earnings allocation are unknown; dilution or connected-party terms could absorb any benefit.

More details

Investment thesis

CNBM has a subscription and deemed-disposal transaction involving Sinoma Science & Technology. Parent ownership, consideration and earnings allocation are unknown; dilution or connected-party terms could absorb any benefit.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

FORGAME

00484

Forgame has acquisitions of listed securities, but no supported link to recurring operating earnings. Portfolio losses, financing costs or related claims could undermine common-share value; a securities purchase alone is not a valuation catalyst.

More details

Investment thesis

Forgame has acquisitions of listed securities, but no supported link to recurring operating earnings. Portfolio losses, financing costs or related claims could undermine common-share value; a securities purchase alone is not a valuation catalyst.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

FAST RETAIL-DRS

06288

Fast Retailing depositary securities have annual-results and trading-resumption news. Recurring earnings, cash conversion and the depositary unit bridge remain unknown; weak results or incorrect rights and price interpretation could invalidate the setup.

More details

Investment thesis

Fast Retailing depositary securities have annual-results and trading-resumption news. Recurring earnings, cash conversion and the depositary unit bridge remain unknown; weak results or incorrect rights and price interpretation could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Fineland Living Services Group Limited

09978

Fineland has an unconditional HK$0.14 mandatory offer after a controlling-stake purchase. Its HK$2.83 dated market close is far above the offer, so this is not positive cash arbitrage; subscription/warrant dilution, control and public float remain the risks.

More details

Investment thesis

Fineland has an unconditional HK$0.14 mandatory offer after a controlling-stake purchase. Its HK$2.83 dated market close is far above the offer, so this is not positive cash arbitrage; subscription/warrant dilution, control and public float remain the risks.

Risk / thesis breaker

['Offer materially below market', 'Subscription/warrant dilution', 'Public-float and control risks']

Fortress Minerals Limited

OAJ

Fortress is an iron-ore producer with a low historical annualized earnings diagnostic, not certified forward cheapness. Debt and leases exceed cash and contracted capex remains; realized ore prices, replacement spending, taxes, dilution and account access determine owner returns.

More details

Investment thesis

Fortress is an iron-ore producer with a low historical annualized earnings diagnostic, not certified forward cheapness. Debt and leases exceed cash and contracted capex remains; realized ore prices, replacement spending, taxes, dilution and account access determine owner returns.

Risk / thesis breaker

Iron ore ASP/volume and dry/wet conversion; capex commitmentUSD4.568m; no maintenance-growth split or FY1 funding/share count confirmed.

恆大 (English name unverified)

1325恆大

恆大 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

恆大 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

大山 (English name unverified)

1615大山

大山 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

大山 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

中纖 (English name unverified)

1718中纖

中纖 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

中纖 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

隴華 (English name unverified)

2424隴華

隴華 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

隴華 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

藝舍-KY (English name unverified)

2724藝舍-KY

藝舍-KY has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

藝舍-KY has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

聯亞 (English name unverified)

3081聯亞

聯亞 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

聯亞 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

千如 (English name unverified)

3236千如

千如 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

千如 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

台星科 (English name unverified)

3265台星科

台星科 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

台星科 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

熱映 (English name unverified)

3373熱映

熱映 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

熱映 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

展達 (English name unverified)

3447展達

展達 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

展達 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

光頡 (English name unverified)

3624光頡

光頡 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

光頡 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

康聯訊 (English name unverified)

3672康聯訊

康聯訊 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

康聯訊 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

天良 (English name unverified)

4127天良

天良 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

天良 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

瑞基 (English name unverified)

4171瑞基

瑞基 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

瑞基 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

永笙-KY (English name unverified)

4178永笙-KY

永笙-KY has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

永笙-KY has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

萬在 (English name unverified)

4543萬在

萬在 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

萬在 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

聯光通 (English name unverified)

4903聯光通

聯光通 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

聯光通 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

前鼎 (English name unverified)

4908前鼎

前鼎 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

前鼎 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

欣厚-KY (English name unverified)

4924欣厚-KY

欣厚-KY has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

欣厚-KY has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

太極 (English name unverified)

4934太極

太極 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

太極 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

乙盛-KY (English name unverified)

5243乙盛-KY

乙盛-KY has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

乙盛-KY has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

同協 (English name unverified)

5460同協

同協 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

同協 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

合邦 (English name unverified)

6103合邦

合邦 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

合邦 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

頎邦 (English name unverified)

6147頎邦

頎邦 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

頎邦 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

高僑 (English name unverified)

6234高僑

高僑 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

高僑 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

點序 (English name unverified)

6485點序

點序 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

點序 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

南六 (English name unverified)

6504南六

南六 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

南六 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

金萬林-創 (English name unverified)

6645金萬林-創

金萬林-創 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

金萬林-創 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

智聯服務 (English name unverified)

6751智聯服務

智聯服務 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

智聯服務 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

宏碁資訊 (English name unverified)

6811宏碁資訊

宏碁資訊 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

宏碁資訊 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

金山電 (English name unverified)

8042金山電

金山電 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

金山電 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

越峰 (English name unverified)

8121越峰

越峰 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

越峰 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

美德醫療-DR (English name unverified)

9103美德醫療-DR

美德醫療-DR has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

美德醫療-DR has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

康那香 (English name unverified)

9919康那香

康那香 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

More details

Investment thesis

康那香 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

1SN.L (issuer name unverified)

1SN.L

An unconfirmed report for 1SN.L (issuer name unverified) describes indicative offer from $MLX.AX at 15p. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

More details

Investment thesis

An unconfirmed report for 1SN.L (issuer name unverified) describes indicative offer from $MLX.AX at 15p. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Colefax Group

CFX.L

An unconfirmed report for Colefax Group describes tender offer for 12% at min 1,350p/105% of 5-day average. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

More details

Investment thesis

An unconfirmed report for Colefax Group describes tender offer for 12% at min 1,350p/105% of 5-day average. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

KMR.L (issuer name unverified)

KMR.L

An unconfirmed report for KMR.L (issuer name unverified) describes non-binding offer from International Resources Holdings. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

More details

Investment thesis

An unconfirmed report for KMR.L (issuer name unverified) describes non-binding offer from International Resources Holdings. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

LDG.L (issuer name unverified)

LDG.L

An unconfirmed report for LDG.L (issuer name unverified) describes revised offer from DBAY at 20p (rejected). This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

More details

Investment thesis

An unconfirmed report for LDG.L (issuer name unverified) describes revised offer from DBAY at 20p (rejected). This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

PNN.L (issuer name unverified)

PNN.L

An unconfirmed report for PNN.L (issuer name unverified) describes rights issue. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

More details

Investment thesis

An unconfirmed report for PNN.L (issuer name unverified) describes rights issue. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Atrium Ljungberg

Ticker unverified

Atrium Ljungberg Q3 2026 shows mixed results. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.

More details

Investment thesis

Atrium Ljungberg Q3 2026 shows mixed results. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.

Risk / thesis breaker

Actual recurring economics, cash/financing and event identity unknown

BEI.SI (issuer name unverified)

BEI.SI

An unconfirmed report for BEI.SI (issuer name unverified) describes partial offer from chairman for 25% at S$0.75. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

More details

Investment thesis

An unconfirmed report for BEI.SI (issuer name unverified) describes partial offer from chairman for 25% at S$0.75. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

BMPS.MI (issuer name unverified)

BMPS.MI

An unconfirmed report for BMPS.MI (issuer name unverified) describes price increased by $ISPM.I to €1.25+1.6x shares. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

More details

Investment thesis

An unconfirmed report for BMPS.MI (issuer name unverified) describes price increased by $ISPM.I to €1.25+1.6x shares. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Charlton Aria Acquisition

CHAR

An unconfirmed report for Charlton Aria Acquisition describes SPAC merger with KQC Quantum. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

More details

Investment thesis

An unconfirmed report for Charlton Aria Acquisition describes SPAC merger with KQC Quantum. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Caribou Biosciences

CRBU

An unconfirmed report for Caribou Biosciences describes strategic review. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

More details

Investment thesis

An unconfirmed report for Caribou Biosciences describes strategic review. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

CVKD (issuer name unverified)

CVKD

An unconfirmed report for CVKD (issuer name unverified) describes strategic review. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

More details

Investment thesis

An unconfirmed report for CVKD (issuer name unverified) describes strategic review. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Camil

Ticker unverified

Camil posts mixed Q2 2026 results as rice prices recover. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.

More details

Investment thesis

Camil posts mixed Q2 2026 results as rice prices recover. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.

Risk / thesis breaker

Actual recurring economics, cash/financing and event identity unknown

Canara Robeco

Ticker unverified

Canara Robeco posts strong Q2 2027 profit growth. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.

More details

Investment thesis

Canara Robeco posts strong Q2 2027 profit growth. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.

Risk / thesis breaker

Actual recurring economics, cash/financing and event identity unknown

Delta Air Lines

Ticker unverified

Delta Air Lines posts Q3 2026 revenue beat, EPS miss. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.

More details

Investment thesis

Delta Air Lines posts Q3 2026 revenue beat, EPS miss. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.

Risk / thesis breaker

Actual recurring economics, cash/financing and event identity unknown

FCG.PS (issuer name unverified)

FCG.PS

An unconfirmed report for FCG.PS (issuer name unverified) describes take-private by parent Figaro Coffee Systems for ₱0.82. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

More details

Investment thesis

An unconfirmed report for FCG.PS (issuer name unverified) describes take-private by parent Figaro Coffee Systems for ₱0.82. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Horizon Aircraft

Ticker unverified

Horizon Aircraft rises on X7 progress in Q1 2027. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.

More details

Investment thesis

Horizon Aircraft rises on X7 progress in Q1 2027. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.

Risk / thesis breaker

Actual recurring economics, cash/financing and event identity unknown

Prabos plus

Ticker unverified

Prabos plus has a CZK4.35m, four-year framework that could generate orders, not firm funded revenue. Actual call-offs, margins and public-share exposure are unknown; nonexecution or low profitability could leave no meaningful common-share benefit.

More details

Investment thesis

Prabos plus has a CZK4.35m, four-year framework that could generate orders, not firm funded revenue. Actual call-offs, margins and public-share exposure are unknown; nonexecution or low profitability could leave no meaningful common-share benefit.

Risk / thesis breaker

Framework utilization, listed eligibility and primary financial underwriting deferred.

Sevenet

Ticker unverified

Sevenet has a PLN4.78m non-framework contract, but its duration and shareholder economics are unknown. Delivery margins, collection and funding determine whether the order adds common-share cash; contract value is not recurring profit.

More details

Investment thesis

Sevenet has a PLN4.78m non-framework contract, but its duration and shareholder economics are unknown. Delivery margins, collection and funding determine whether the order adds common-share cash; contract value is not recurring profit.

Risk / thesis breaker

Reduced budget deferred primary financial underwriting and full notice.

Triolab AB / potential AddLife parent

Ticker unverified

Triolab is named for SEK92.576m blood-gas and oximetry contracts, but its listed-parent exposure is unverified. Contract margins and actual ownership determine any common-share benefit; incorrect parent attribution or delivery costs could invalidate the setup.

More details

Investment thesis

Triolab is named for SEK92.576m blood-gas and oximetry contracts, but its listed-parent exposure is unverified. Contract margins and actual ownership determine any common-share benefit; incorrect parent attribution or delivery costs could invalidate the setup.

Risk / thesis breaker

Reduced budget deferred full notice, parent, issuer filings and price.

CSLM Digital Asset Acquisition III

KOYN

An unconfirmed report for CSLM Digital Asset Acquisition III describes SPAC merger with First Digital. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

More details

Investment thesis

An unconfirmed report for CSLM Digital Asset Acquisition III describes SPAC merger with First Digital. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

Poonawalla Fincorp

Ticker unverified

Poonawalla Fincorp posts strong Q2 2026 growth. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.

More details

Investment thesis

Poonawalla Fincorp posts strong Q2 2026 growth. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.

Risk / thesis breaker

Actual recurring economics, cash/financing and event identity unknown

Recordati

REC.MI

An unconfirmed report for Recordati describes price increase by CVC consortium to €53. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

More details

Investment thesis

An unconfirmed report for Recordati describes price increase by CVC consortium to €53. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

RXO, Inc. Common Stock

RXO

An unconfirmed report for RXO, Inc. Common Stock describes acquisition by $CHRW for $17.25+0.0856x shares. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

More details

Investment thesis

An unconfirmed report for RXO, Inc. Common Stock describes acquisition by $CHRW for $17.25+0.0856x shares. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.

Risk / thesis breaker

Cash conversion, financing and exact rights are unverified.

SSP Group

Ticker unverified

SSP Group shares fall as cash flow outlook softens in Q4 2026. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.

More details

Investment thesis

SSP Group shares fall as cash flow outlook softens in Q4 2026. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.

Risk / thesis breaker

Actual recurring economics, cash/financing and event identity unknown

Seven & i Holdings

Ticker unverified

Seven & i Holdings tops Q2 2026 forecasts. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.

More details

Investment thesis

Seven & i Holdings tops Q2 2026 forecasts. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.

Risk / thesis breaker

Actual recurring economics, cash/financing and event identity unknown

Tryg

Ticker unverified

Tryg Q3 2026 profit strength lifts shares 3.8%. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.

More details

Investment thesis

Tryg Q3 2026 profit strength lifts shares 3.8%. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.

Risk / thesis breaker

Actual recurring economics, cash/financing and event identity unknown

Volution Group

Ticker unverified

Volution Group posts strong FY 2026, shares steady in H2 2026. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.

More details

Investment thesis

Volution Group posts strong FY 2026, shares steady in H2 2026. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.

Risk / thesis breaker

Actual recurring economics, cash/financing and event identity unknown

AI OKTO CORP.

AIOK

Aiok received two LPG carriers andUS$45m cash in Toro spin-off, alongside aUS$25m senior convertible preferred claim held byToro. Standalone fixtures/cash and capital terms are the catalysts; common dilution, senior conversion, liabilities and cash restrictions are not underwritten.

More details

Investment thesis

Aiok received two LPG carriers andUS$45m cash in Toro spin-off, alongside aUS$25m senior convertible preferred claim held byToro. Standalone fixtures/cash and capital terms are the catalysts; common dilution, senior conversion, liabilities and cash restrictions are not underwritten.

Risk / thesis breaker

Preferred/control, dilution, liability and cash restrictions

ANGIODYNAMICS INC

ANGO

No supported investment thesis is established for ANGIODYNAMICS INC yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.

More details

Investment thesis

No supported investment thesis is established for ANGIODYNAMICS INC yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.

Risk / thesis breaker

Unknown recurring economics, senior claims, dilution and execution

Black Hills Corporation

BKH

Black Hills has signed long-term agreements to serve Google, with management expecting project earnings to begin in 2027 and reach about $150m in 2030. The opportunity depends on funding a $1.8bn build without excessive common dilution. Construction, financing or regulatory costs could absorb the distant earnings benefit.

More details

Investment thesis

Black Hills has signed long-term agreements to serve Google, with management expecting project earnings to begin in 2027 and reach about $150m in 2030. The opportunity depends on funding a $1.8bn build without excessive common dilution. Construction, financing or regulatory costs could absorb the distant earnings benefit.

Risk / thesis breaker

Financing, dilution, construction, merger/claims allocation

Commerce.com, Inc.

CMRC

Commerce.com sells commerce software. Its announced cost reset could improve cash generation as savings arrive in 2027, but customer contraction, recurring stock compensation and software investment can absorb the benefit. The updated cash bridge remains conditional, and unverified note settlement or dilution is the principal thesis-breaker.

More details

Investment thesis

Commerce.com sells commerce software. Its announced cost reset could improve cash generation as savings arrive in 2027, but customer contraction, recurring stock compensation and software investment can absorb the benefit. The updated cash bridge remains conditional, and unverified note settlement or dilution is the principal thesis-breaker.

Risk / thesis breaker

['Grossprofit/reinvestment offsets', 'Planexpense8.5-26.3m notcashschedule', 'Unverifiednote/couponsettlement', 'Currentdilution', '150m2028principal/refinancing', 'Noexecutabledepth']

Crescent Energy Co

CRGY

No supported investment thesis is established for Crescent Energy Co yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.

More details

Investment thesis

No supported investment thesis is established for Crescent Energy Co yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.

Risk / thesis breaker

Unknown recurring economics, senior claims, dilution and execution

HELEN OF TROY LTD

HELE

No supported investment thesis is established for HELEN OF TROY LTD yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.

More details

Investment thesis

No supported investment thesis is established for HELEN OF TROY LTD yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.

Risk / thesis breaker

Unknown recurring economics, senior claims, dilution and execution

Main Street Capital CORP

MAIN

No supported investment thesis is established for Main Street Capital CORP yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.

More details

Investment thesis

No supported investment thesis is established for Main Street Capital CORP yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.

Risk / thesis breaker

Unknown recurring economics, senior claims, dilution and execution

MSC INCOME FUND, INC.

MSIF

No supported investment thesis is established for MSC INCOME FUND, INC. yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.

More details

Investment thesis

No supported investment thesis is established for MSC INCOME FUND, INC. yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.

Risk / thesis breaker

Unknown recurring economics, senior claims, dilution and execution

Oil-Dri Corporation of America

ODC

Oil-Dri has strong co-pack demand and historical cash generation, offering a route to better operating cash. Annual operating income was nevertheless flat, and a legal settlement and Amlan quarter rebound cannot establish recurring growth. Weak underlying margins, working-capital needs or higher capex could defeat the setup.

More details

Investment thesis

Oil-Dri has strong co-pack demand and historical cash generation, offering a route to better operating cash. Annual operating income was nevertheless flat, and a legal settlement and Amlan quarter rebound cannot establish recurring growth. Weak underlying margins, working-capital needs or higher capex could defeat the setup.

Risk / thesis breaker

Freight inflation, retail concentration/promotions, Amlan rebound, higher reinvestment.

Resources Connection, Inc.

RGP

Resources Connection is attempting to rebuild consulting demand through sales hiring and utilization improvements. Management expects hiring benefits mainly in the last two fiscal quarters; continuing revenue contraction and negative adjusted EBITDA could consume the recovery before it reaches common shareholders.

More details

Investment thesis

Resources Connection is attempting to rebuild consulting demand through sales hiring and utilization improvements. Management expects hiring benefits mainly in the last two fiscal quarters; continuing revenue contraction and negative adjusted EBITDA could consume the recovery before it reaches common shareholders.

Risk / thesis breaker

Pre-call USD equity cap, exact call clock, IBKR line/access and analyst completion unknown.

RCI HOSPITALITY HOLDINGS, INC.

RICK

No supported investment thesis is established for RCI HOSPITALITY HOLDINGS, INC. yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.

More details

Investment thesis

No supported investment thesis is established for RCI HOSPITALITY HOLDINGS, INC. yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.

Risk / thesis breaker

Unknown recurring economics, senior claims, dilution and execution

Tilray Brands, Inc.

TLRY

No supported investment thesis is established for Tilray Brands, Inc. yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.

More details

Investment thesis

No supported investment thesis is established for Tilray Brands, Inc. yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.

Risk / thesis breaker

Unknown recurring economics, senior claims, dilution and execution

EBR Systems Inc

EBR

EBR sells WiSE wireless cardiac pacing; Q3 implants and preliminary revenue fell despite more activated accounts. Repeat usage, site PMA and cash/debt runway are the catalysts, but losses, cash burn and additional recapitalization are the breakers; the source CDI line prohibits US persons except QIB.

More details

Investment thesis

EBR sells WiSE wireless cardiac pacing; Q3 implants and preliminary revenue fell despite more activated accounts. Repeat usage, site PMA and cash/debt runway are the catalysts, but losses, cash burn and additional recapitalization are the breakers; the source CDI line prohibits US persons except QIB.

Risk / thesis breaker

Source-reviewed ASX CDI terms prohibit US persons except QIB; ordinary individual access not established. Underlying common is not substituted. ['unsupported FY1/FY2 and matched peers', 'official adjusted CSPA not verified', 'current gross capital/cash and exact account permission unresolved']

Xin Yuan Enterprises Group Limited

01748

Xin Yuan has a possible HK$2.21 cash offer conditional on resuming its suspended shares before October30. The old HK$1.76 trade is not an available entry; resumption, greater-than50% acceptance, financing and adverse-change terms can break the event.

More details

Investment thesis

Xin Yuan has a possible HK$2.21 cash offer conditional on resuming its suspended shares before October30. The old HK$1.76 trade is not an available entry; resumption, greater-than50% acceptance, financing and adverse-change terms can break the event.

Risk / thesis breaker

Dated source establishes suspension; current resumption/executable entry not verified. ['Suspension', 'Resumption/offer may fail', 'Acceptance condition', 'MAC', 'No executable price']